The generic pill made by India's Cipla Ltd combines the generic HIV-fighting drugs lamivudine, stavudine and nevirapine.
This is the first pill of its kind that will be available for children under age 12 under the U.S. program.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!